Core Guide

What Is Tirzepatide? A Simple Guide for Nigerians

You've probably heard about a medication called tirzepatide making waves in weight loss circles. Let's break down what it is, how it works, and whether it might be right for you.

Updated January 2026 | 12 min read

The Basics: What Tirzepatide Actually Is

Tirzepatide is a prescription medication used for weight loss and diabetes management. If you've heard of Mounjaro or Zepbound, those are brand names for tirzepatide made by the pharmaceutical company Eli Lilly. Think of it like how Panadol and Paracetamol are different names for the same medication.

What makes tirzepatide special is that it belongs to a new class of weight loss medications that work with your body's natural systems. Unlike older weight loss pills that just reduced appetite through stimulants, tirzepatide mimics hormones your body already produces. This means it works more naturally and, for many people, more effectively.

The medication comes as a weekly injection that you can give yourself at home. Yes, the idea of injecting yourself might sound intimidating, but the needle is tiny and most people barely feel it. We'll cover the injection process in detail in another guide.

How Tirzepatide Works in Your Body

To understand tirzepatide, you need to know about hormones called incretins. Don't worry, we'll keep this simple. When you eat food, your gut releases these hormones to help manage what happens next. Two important ones are GLP-1 and GIP.

GLP-1 (glucagon-like peptide-1) tells your brain you're full, slows down how fast food leaves your stomach, and helps control blood sugar. Your body makes this naturally, but it breaks down very quickly, within minutes of being released.

GIP (glucose-dependent insulinotropic polypeptide) does similar things. It also helps with feelings of fullness and blood sugar management, and it has additional effects on how your body stores and uses fat.

Here's where tirzepatide becomes interesting. While semaglutide only mimics GLP-1, tirzepatide mimics both GLP-1 and GIP. This dual action is why some studies show tirzepatide produces more weight loss than GLP-1-only medications.

When you inject tirzepatide, it stays active in your body for about a week. This constant presence means your appetite is consistently reduced, you feel satisfied with less food, and your blood sugar stays more stable. No more fighting constant hunger or dealing with intense cravings.

The Dual Action Advantage

Think of GLP-1 and GIP as two different managers working together. GLP-1 is like your appetite manager. It talks to your brain's hunger center and says "we've had enough food, no need to eat more." It also tells your stomach to take its time processing food, so you feel full longer after meals.

GIP is more like your metabolism manager. It helps your body handle the energy from food more efficiently. Some research suggests GIP also affects how your body stores fat and may help preserve muscle while you're losing weight.

When you compare tirzepatide versus semaglutide, the dual action of tirzepatide appears to produce stronger effects. In clinical trials, people taking tirzepatide lost more weight on average than those taking semaglutide. However, both medications are highly effective, and the "best" choice depends on your individual situation.

The dual action also seems to cause fewer nausea issues for some people. While nausea is still possible with tirzepatide, the GIP component may help balance out some of the GLP-1 effects on the stomach. Many doctors find that patients tolerate tirzepatide quite well, especially when doses are increased gradually.

How Much Weight Can You Lose?

Let's talk numbers, because that's probably what you're most curious about. In clinical trials, participants taking tirzepatide lost an average of significant of their body weight. For someone weighing 100kg, that's 15-22kg of weight loss.

To put this in perspective, this level of weight loss was previously only achievable through bariatric surgery. Now it's possible with a weekly injection and lifestyle changes.

The results from published clinical trials were remarkable:

  • At the 5mg dose: Average weight loss of about 15%
  • At the 10mg dose: Average weight loss of about 19%
  • At the 15mg dose: Average weight loss of about 21%

Keep in mind these are averages. Some people lose more, some lose less. Your results will depend on factors like your starting weight, how well you tolerate the medication, and whether you make lifestyle changes alongside taking tirzepatide.

For a more detailed look at what to expect week by week, check our tirzepatide results timeline.

Who Can Use Tirzepatide?

Tirzepatide is approved for adults with obesity (BMI of 30 or higher) or adults who are overweight (BMI of 27 or higher) with at least one weight-related health condition like high blood pressure, high cholesterol, or type 2 diabetes.

A quick way to check your BMI: if you're 170cm tall and weigh over 87kg, your BMI is likely 30 or higher. If you're 160cm tall and weigh over 77kg, you're in the same category. Your doctor can help you calculate your exact BMI.

Some people should not use tirzepatide:

  • Those with a personal or family history of medullary thyroid cancer
  • People with Multiple Endocrine Neoplasia syndrome type 2
  • Those with a history of pancreatitis
  • Pregnant or breastfeeding women
  • People with severe kidney disease

For a complete guide on who should avoid these medications, read our article on who should not take GLP-1 medications.

What About Side Effects?

Like all medications, tirzepatide can cause side effects. The most common ones are related to your digestive system, which makes sense given how the medication works.

Common side effects include:

  • Nausea (usually worst in the first few weeks)
  • Diarrhea or constipation
  • Reduced appetite (this is partly how it works)
  • Stomach discomfort or bloating
  • Fatigue in the early weeks

The good news is that most side effects are mild to moderate and improve as your body adjusts. This is why doctors start you on a low dose and gradually increase it. By giving your body time to adapt, you minimize discomfort.

For tips on handling the most common complaint, see our guide on managing nausea with GLP-1 medications. For a comprehensive look at what to expect, check out tirzepatide side effects.

Serious side effects are rare but can include pancreatitis (inflammation of the pancreas), gallbladder problems, and allergic reactions. If you experience severe stomach pain, persistent vomiting, or signs of an allergic reaction, seek medical attention immediately.

Tirzepatide in Nigeria

Accessing tirzepatide in Nigeria is becoming easier, though it requires going through proper medical channels. The brand name Mounjaro® may not be readily available in Nigerian pharmacies, but compounded tirzepatide prepared by licensed compounding pharmacies offers a more accessible option.

What's compounded tirzepatide? It's the same medication made by specialized pharmacies rather than big pharmaceutical companies. The active ingredient is identical; the difference is in production scale and branding. Many Nigerians are accessing compounded GLP-1 medications because they're more affordable and more readily available.

Working with a telemedicine service or local clinic that specializes in weight management can help you access tirzepatide safely. These services typically:

  • Evaluate whether you're a good candidate
  • Prescribe the appropriate starting dose
  • Provide guidance on injection technique
  • Monitor your progress and adjust dosing
  • Help manage any side effects

For more on accessing these medications, see our guide on how to get GLP-1 medications in Nigeria.

Common Questions About Tirzepatide

How long do I need to take tirzepatide?

Tirzepatide is typically a long-term medication. Studies show that most people regain weight if they stop taking it, similar to how blood pressure often returns if you stop blood pressure medication. Your doctor will help you develop a long-term plan that works for your situation.

Can I take tirzepatide if I don't have diabetes?

Yes. While tirzepatide was initially approved for diabetes (as Mounjaro), it's now also approved specifically for weight loss (as Zepbound) in people without diabetes. The dosing and approach may differ slightly between the two uses.

What's the difference between tirzepatide and Mounjaro?

Nothing, really. Mounjaro is a brand name for tirzepatide made by Eli Lilly. Zepbound is another brand name for the same medication, but marketed specifically for weight loss. The active ingredient is identical.

How quickly will I see results?

Most people notice reduced appetite within the first week or two. Visible weight loss typically begins within the first month, with the most significant losses occurring over 6-12 months. Patience is important, as the medication works best when given time and combined with healthy eating.

Is tirzepatide safe?

Tirzepatide has been extensively studied in clinical trials with thousands of participants. It's approved by major regulatory agencies including the FDA. Like all medications, it has potential side effects, but for most people the benefits outweigh the risks. A medical evaluation before starting ensures it's appropriate for you.

Key Takeaways

  • Tirzepatide is a weekly injection that mimics two natural hormones (GLP-1 and GIP) to reduce appetite and improve metabolism
  • Clinical trials show average weight loss of significant of body weight
  • Common side effects like nausea usually improve as your body adjusts
  • Compounded tirzepatide is available in Nigeria through proper medical channels

Ready to Start Your Weight Loss Journey?

Our medical team can help determine if tirzepatide is right for you. Get a consultation and personalized treatment plan.

Get Started Today

Related Articles

References

  1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (clinical research-1). N Engl J Med. 2022.
  2. Garvey WT, et al. Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes (clinical research-2). Lancet. 2023.

Medically Reviewed by Dr. Babatunde Afolabi

MBBS, FRCP, PhD - Endocrinology

Content reviewed by qualified healthcare professionals for accuracy.